Follow
William E Evans
William E Evans
Verified email at stjude.org
Title
Cited by
Cited by
Year
Pharmacogenomics: translating functional genomics into rational therapeutics
WE Evans, MV Relling
science 286 (5439), 487-491, 1999
32321999
Treatment of acute lymphoblastic leukemia
CH Pui, WE Evans
New England Journal of Medicine 354 (2), 166-178, 2006
25682006
Treatment of acute lymphoblastic leukemia
CH Pui, WE Evans
New England Journal of Medicine 354 (2), 166-178, 2006
25682006
Pharmacogenomics—drug disposition, drug targets, and side effects
WE Evans, HL McLeod
New England Journal of Medicine 348 (6), 538-549, 2003
23922003
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
EJ Yeoh, ME Ross, SA Shurtleff, WK Williams, D Patel, R Mahfouz, ...
Cancer cell 1 (2), 133-143, 2002
23462002
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
CG Mullighan, S Goorha, I Radtke, CB Miller, E Coustan-Smith, JD Dalton, ...
Nature 446 (7137), 758-764, 2007
19822007
Acute lymphoblastic leukemia
CH Pui, MV Relling, JR Downing
New England Journal of Medicine 350 (15), 1535-1548, 2004
18802004
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
J Zhang, L Ding, L Holmfeldt, G Wu, SL Heatley, D Payne-Turner, ...
Nature 481 (7380), 157-163, 2012
16362012
Treating childhood acute lymphoblastic leukemia without cranial irradiation
CH Pui, D Campana, D Pei, WP Bowman, JT Sandlund, SC Kaste, ...
New England Journal of Medicine 360 (26), 2730-2741, 2009
12902009
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ...
New England journal of medicine 371 (11), 1005-1015, 2014
12702014
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
ML Den Boer, M van Slegtenhorst, RX De Menezes, MH Cheok, ...
The lancet oncology 10 (2), 125-134, 2009
9972009
Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance
CR Yates, EY Krynetski, T Loennechen, MY Fessing, HL Tai, CH Pui, ...
Annals of internal medicine 126 (8), 608-614, 1997
9521997
Moving towards individualized medicine with pharmacogenomics
WE Evans, MV Relling
Nature 429 (6990), 464-468, 2004
9492004
Mercaptopurine Therapy Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene Locus
MV Relling, ML Hancock, GK Rivera, JT Sandlund, RC Ribeiro, ...
Journal of the National Cancer Institute 91 (23), 2001-2008, 1999
8271999
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia
CH Pui, RC Ribeiro, ML Hancock, GK Rivera, WE Evans, SC Raimondi, ...
New England Journal of Medicine 325 (24), 1682-1687, 1991
8201991
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.
R MV, G EE, S WJ, S K, P CH, Y SW, S CM, C M, E WE, H JK, S M, K TE, ...
Clinical Pharmacology & Therapeutics 93 (4), 324-325, 2013
807*2013
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.
R MV, G EE, S WJ, S K, P CH, Y SW, S CM, C M, E WE, K TE, ...
Clinical Pharmacology & Therapeutics 89 (3), 387-391, 2011
8072011
Childhood acute lymphoblastic leukemia: progress through collaboration
CH Pui, JJ Yang, SP Hunger, R Pieters, M Schrappe, A Biondi, A Vora, ...
Journal of Clinical Oncology 33 (27), 2938, 2015
8032015
Pharmacogenomics and individualized drug therapy
M Eichelbaum, M Ingelman-Sundberg, WE Evans
Annu. Rev. Med. 57, 119-137, 2006
7972006
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia
KG Roberts, RD Morin, J Zhang, M Hirst, Y Zhao, X Su, SC Chen, ...
Cancer cell 22 (2), 153-166, 2012
7672012
The system can't perform the operation now. Try again later.
Articles 1–20